Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-26-333719
Filing Date
2026-08-05
Accepted
2026-08-05 06:01:41
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5186
  Complete submission text file 0001193125-26-333719.txt   6663
Mailing Address RAPPORT THERAPEUTICS, INC. 1325 BOYLSTON STREET, SUITE 401 BOSTON MA 02215
Business Address
PAUL STEVEN M (Filed by) CIK: 0001237564 (see all company filings)

Type: SCHEDULE 13G

Mailing Address 6 TIDE STREET SUITE 400 BOSTON MA 02110
Business Address 6 TIDE STREET SUITE 400 BOSTON MA 02110 617-807-4062
Seaport Therapeutics, Inc. (Subject) CIK: 0002042347 (see all company filings)

EIN.: 992235719 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-95656 | Film No.: 261241101
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)